Population pharmacokinetic analysis of colistin in burn patients

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 5, 2013, Pages 2141-2146

  Lee, Jongtae ^a   Han, Seunghoon ^a   Jeon, Sangil ^a   Hong, Taegon ^a   Song, Wonkeun ^b   Woo, Heungjeon ^c   Yim, Dong Seok ^a  

^a The Catholic University of Korea   (South Korea)

^b Hallym University College of Medicine   (South Korea)

^c Hallym University Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIMETHATE; COLISTIN; CREATININE; DRUG METABOLITE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BODY SURFACE; BURN; BURN PATIENT; CLINICAL ARTICLE; CREATININE CLEARANCE; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; SIMULATION; TANDEM MASS SPECTROMETRY; TURNOVER TIME;

ACINETOBACTER BAUMANNII; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; BIOTRANSFORMATION; BURNS; COLISTIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HALF-LIFE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PSEUDOMONAS AERUGINOSA; TREATMENT OUTCOME;

EID: 84876228231     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00271-13     Document Type: Article

References (25)

1. Falagas ME, Kasiakou SK. 2005. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin. Infect. Dis. 40:1333-1341.
2. Brown JM, Dorman DC, Roy LP. 1970. Acute renal failure due to overdosage of colistin. Med. J. Aust. 2:923-924.
3. Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE. 1970. Adverse effects of sodium colistimethate: manifestations and specific reaction rates during 317 courses of therapy. Ann. Intern. Med. 72:857-868.
4. Lim LM, Neang Ly Anderson D, Yang JC, Macander L, Jarkowski A, III, Forrest A, Bulitta JB, Tsuji BT. 2010. Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing. Pharmacotherapy 30:1279-1291.
5. Littlewood JM, Koch C, Lambert PA, Høiby N, Elborn JS, Conway SP, Dinwiddie R, Duncan-Skingle F. 2000. A ten year review of colomycin. Respir. Med. 94:632-640.
6. Livermore D. 2002. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin. Infect. Dis. 34:634-640.
7. Michalopoulos A, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME. 2005. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin. Microbiol. Infect. 11:115-121.
8. Jarvis WR, Edwards JR, Culver DH, Hughes JM, Horan T, Emori TG, Banerjee S, Tolson J, Henderson T, Gaynes RP, Martone WJ. 1991. Nosocomial infection rates in adult and pediatric intensive care units in the United States. Am. J. Med. 91(Suppl 3B):185S-191S.
9. Santucci SG, Gobara S, Santos CR, Fontana C, Levin AS. 2003. Infections in a burn intensive care unit: experience of seven years. J. Hosp. Infect. 53:6-13.
10. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K. 2009. International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323-2329.
11. Goverman J, Weber JM, Keaney TJ, Sheridan RL. 2007. Intravenous colistin for the treatment of multi-drug resistant, gram-negative infection in the pediatric burn population. J. Burn Care Res. 28:421-426.
12. Garonzik SM, Li J, Thamlikitkul V, Paterson DL, Shoham S, Jacob J, Silveira FP, Forrest A, Nation RL. 2011. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients. Antimicrob. Agents Chemother. 55:3284-3294.
13. Li J, Coulthard K, Milne R, Nation RL, Conway S, Peckham D, Etherington C, Turnidge J. 2003. Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis. J. Antimicrob. Chemother. 52:987-992.
14. Plachouras D, Karvanen M, Friberg LE, Papadomichelakis E, Antoniadou A, Tsangaris I, Karaiskos I, Poulakou G, Kontopidou F, Armaganidis A, Cars O, Giamarellou H. 2009. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gramnegative bacteria. Antimicrob. Agents Chemother. 53:3430-3436.
15. Reed MD, Stern RC, O'Riordan MA, Blumer JL. 2001. The pharmacokinetics of colistin in patients with cystic fibrosis. J. Clin. Pharmacol. 41: 645-654.
16. Weinbren MJ. 1999. Pharmacokinetics of antibiotics in burn patient. J. Antimicrob. Chemother. 44:319-327.
17. Dudhani RV, Turnidge JD, Coulthard K, Milne RW, Rayner CR, Li J, Nation RL. 2010. Elucidation of the pharmacokinetic/pharmacodynamics determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models. Antimicrob. Agents Chemother. 54:1117-1124.
18. Gobin P, Lemaitre F, Marchand S, Couet W, Olivier JC. 2010. Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography- tandem mass spectrometry. Antimicrob. Agents Chemother. 54:1941-1948.
19. Jansson B, Karvannen M, Cars O, Plachouras D, Friberg LE. 2009. Quantitative analysis of colistin A and B in plasma and culture media using a simple precipitation step followed by LC/MS/MS. J. Pharm. Biomed. Anal. 49:760-767.
20. Cockcroft D, Gault M. 1976. Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41.
21. Mizuyachi K, Hara K, Wakamatsu A, Nohda S, Hirama T. 2011. Safety and pharmacokinetic evaluation of intravenous colistin methanesulfonate sodium in Japanese healthy male subjects. Curr. Med. Res. Opin. 27:2261-2270.
22. Markou N, Apostolakos H, Koumoudiou C, Athanasiou M, Koutsoukou A, Alamanos I, Gregorakos L. 2003. Intravenous colistin in the treatment of sepsis from multiresistant gram-negative bacilli in critically ill patients. Crit. Care. 7:R78-R83.
23. Li J, Milne RW, Nation RL, Turnidge JD, Smeaton TC, Coulthard K. 2004. Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate. J. Antimicrob. Chemother. 53:837-840.
24. Li J, Milne RW, Nation RL, Turnidge JD, Smeaton TC, Coulthard K. 2003. Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration. Antimicrob. Agents Chemother. 47:781-785.
25. Demling RH. 2005. The burn edema process: current concepts. J. Burn Care Rehabil. 26:207-227.